Investor Relations
 
Stock Exchange Compliances
Section is devoted to all Stock Exchange Compliances. The Equity Shares of the Company are listed on the Bombay Stock Exchange (BSE), Mumbai, India under the Stock Symbol. To apply for any specific document not listed on this page, please feel free to write to us using the contact form.
 
Registrar & Transfer Agents
Purva Sharegistry India (P) Ltd.
Unit No 9, Shiv Shakti Industrial Estate,
JR Boricha Marg, Lower Parel (E).
Mumbai 400 011
Ph: 022-2301 6761/8261
Fax: 91-22-2301 2517
Email: support@purvashare.com 
Managing Director / Chief Financial Officer
Mr. Fredun Medhora
Phone: 022-4031 8111
Email ID: business@fredungroup.com
 
Compliances
Various Compliances filed with the Stock exchange are listed below. Investors can download the same directly from here for their records.
 
 
BOARD OF DIRECTORS
   
 
ANNUAL REPORTS
   
 
FINANCIAL RESULTS
   
 
EXTRACT OF THE ANNUAL RETURN
   
 
CORPORATE GOVERNANCE
   
 
SHAREHOLDING PATTERN
   
 
INFO FOR SHAREHOLDERS
   
 
NEWS AND ANNOUNCEMENT
   
 
OTHER FILLINGS WITH
STOCK EXCHANGES
   
 
STATUTORY DOCUMENTS
AND INFORMATION
   
 
UNCLAIMED DIVIDEND
   
 
GENERAL INFORMATION
OTHER FILLINGS WITH STOCK EXCHANGES
   
► Certificate under Reg 40(9)- March 2023
   
► Certificate under Reg 7(3) - March 2023.pdf
   
► Declaration with regard to not being a Large Corporate - March 2023
   
► Reconciliation of Share Capital Audit Report - March 2023
   
► Compliance Certificate under Reg 74(5)- March 2023
   
► Statutory Aud Certificate
   
► Compliance Certificate under Regulation 74 (5) September 2021
   
► Reconciliation of Share Capital Audit Report - June 2021
   
► Compliance Certificate under Regulation 74 (5) - June 2021
   
► Reconciliation of Share Capital Audit Report - March 2021
   
► Certificate Under Regulation 40 - March 2021
   
► Declaration with regards to not being a large corporate
   
► Compliance Certificate under Regulation 74 (5) - March 2021
   
► Declaration for Corporate Governance Exemption 2021-22
   
► Certificate under Regulation 7 (3) - March 2021
   
► Reconciliation of Share Capital Audit Report - December 2020
   
► Compliance Certificate under Regulation 74(5) - December 2020
   
► Certificate under Regulation 40 - September 2020
   
► Reconciliation of Share Capital Audit Report - September 2020
   
► Certificate under Regulation 7(3) - September 2020
   
► Compliance Certificate under Regulation 74 (5) September 2020
   
► Reconciliation of Share Capital Audit Report for - June 2020
   
► Compliance Certificate under Regulation 74(5)- June 2020
   
► Reconciliation of Share Capital Audit Report - March 2020
   
► Declaration with regards to not being a large corporate
   
► Declaration for Corporate Governance Exemption 2020-21
   
► Compliance Certificate under Regulation 74(5) - March 2020
   
► Compliance Certificate under Regulation 40 - March 2020
   
► Compliance Certificate under Regulation 7(3)
   
► Reconciliation of Share Capital Audit Report - Dec 2019
   
► Reconciliation of Share Capital Audit Report - Sept 2019
   
► Certificate under Regulation 40 - Sept 2019
   
► Certificate under Regulation 7(3) - September 2019
   
► Compliance Certificate under Regulation 74(5) - Sept 2019
   
► Reconciliation of Share Capital Audit Report - June 2019
   
► Compliance Certificate under Regulation 74(5) - June 2019
   
► Certificate under Regulation 40 - March 2019
   
► Certificate under Regulation 7(3) - March 2019
   
► Reconciliation of Share Capital Audit Report - March 2019
   
► Declaration for Corporate Governance Exemption 2019 - 20
   
► Reconciliation of Share Capital Audit Report - Dec 2018
   
► Reconciliation of Share Capital Audit Report - Sept 2018
   
► Certificate under Reg. 40 - September 2018
   
► Certificate under Reg. 7(3) - September 2018
   
► Reconciliation of Share Capital Audit Report - June 2018
   
► Investors Grievances Report - June 2018
   
► Certificate under Reg. 7(3) - March 2018
   
► Certificate under Reg. 40 - March 2018
   
► Reconciliation of Share Capital Audit Report - March 2018
   
► Investors Grievances Report - March 2018
   
► Declaration for Corporate Governance Exemption 2018-19
   
► Reconciliation of Share Capital Audit Report - December 2017
   
► Investors Grievances Report - December 2017
   
► Reg 7(3) Certificate - September 2017
   
► Investors Grievances Report - September 2017
   
► Reg 40 Certificate - September 2017
   
► Reconciliation of Share Capital Audit Report - September 2017
   
 
 
 
 
 
Home Company Profile Pharmaceutical Healthcare Fredna Global Presence Careers Employee Login Contact Us Investor Relations
© All rights reserved  |  Fredun Group  |  2014-15 CIN No: L24239MH1987PLC043662